BioInvent and Transgene has enrolled first patient in Phase I/IIa trial of novel oncolytic virus BT-001 in solid tumors Mar 1, 2021 01:52AM
BioInvent and Transgene to Present Data on BT-001, an Oncolytic Virus Encoding for an Anti-CTLA4 Antibody, at Upcoming Congresses Mar 3, 2020 03:02AM
BioInvent and Transgene Announce Compelling Preclinical Data for BT-001 in Solid Tumors Dec 11, 2019 02:57AM
BioInvent Signs Manufacturing Agreement With Cancer Research UK Expected to Generate Approximately SEK 30 Million (~$3 Million) Oct 23, 2019 07:45AM
BioInvent and Transgene Extend Their Collaboration to Develop Multifunctional Oncolytic Viruses for the Treatment of Solid Tumors Mar 26, 2019 03:59AM